2 completed, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow ensitrelvir: new trials by email Literature Review of ensitrelvir trials Research Report on ensitrelvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection S-217622, Placebo - SARS-CoV-2 Infection | Phase 3 | Completed | Shionogi | 3701 | 2023-06-09 | 2026-10-07 |
| Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir) Shionogi Protease Inhibitor (S-217622), placebo - COVID-19 | Phase 3 | Terminated | University of Minnesota | 602 | 2022-12-23 | 2026-09-24 |
| A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 S-217622, Placebo - SARS-CoV-2 Infection | Phase 3 | Completed | Shionogi | 2093 | 2022-08-03 | 2026-11-17 |
COVID-19 (3)
Shionogi (2) · University of Minnesota (1)
Argentina (3) · Japan (3) · South Africa (3) · United States (3) · Brazil (2) · Mexico (2) · Peru (2) · Poland (2) · Thailand (2) · Uganda (2) · Australia (1) · Colombia (1) · Denmark (1) · Georgia (1) · Germany (1)
Cavan Reilly, PhD (1) · Jason Baker, MD (1)
PMID 39960062, PMID 41672106, PMID 42127390
2023 (1)